Star Health Shares Slides 4% On Q2, 50% Profit Cut To ₹349 Crore
By Shishta Dutta | Published at: Oct 29, 2025 02:55 PM IST
Mumbai, October 29, 2025 – Rating Star Health and Allied Insurance Company Ltd shares fell more than 4% to ₹474.65 in early morning trade on Wednesday after the insurer reported a drastic fall of 50.7% in net profit year to year between July and September of FY26. The stock has been pressured since it opened the market and has gone further down amid a low investor mood following second-quarter results.
Q2 FY26 Financial Performance
The company’s gross premium written increased marginally to ₹4,423.8 crore in Q2 FY26, while the net premium earned increased by 10.2%. But profit dropped sharply by 50.7% to ₹54.9 crore, as high commission payments and rising expenditure eroded overall profitability.
Stock Performance
As of 13:15 hours, the share of Star Health and Allied Insurance Company Ltd was trading at ₹480.45, down 14.55 or 2.94% from its previous close of ₹494.65. The share opened at ₹480 and traded between ₹484.40 and ₹461.95, with a high and low. the 52-Week Range in between ₹327.30 – ₹548.95. The company was trading with a Volume of 9.87 lakh shares, a Market Cap of ₹27,911.79 crore, and a VWAP of ₹477.16.
Star Health and Allied Insurance Company Ltd has been listed on the NSE and BSE since December 10, 2021, and is the biggest standalone health insurer in India. Star Health offers both individual and group health insurance and is a constituent of the Nifty Smallcap 250 index in the General Insurance sector.
REF: https://nsearchives.nseindia.com/corporate/STARHEALTH_28102025194016_PressReleasePAT.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
